When ATH:
R03BC03
Characteristic.
Yellow powder, water-soluble. Molecular weight 415,3.
Pharmacological action.
Anti-asthma.
Application.
Bronchial obstruction: asthma different genesis, incl. asthma physical effort, bronhospasticskie reaction, cold air induced, inhaled allergens, atmospheric pollution, chronic obstructive bronchitis.
Contraindications.
Hypersensitivity (incl. a fluorocarbon), childhood (to 12 years).
Restrictions apply.
Pregnancy (I trimester) and breastfeeding.
Pregnancy and breast-feeding.
With care prescribe during pregnancy (especially in the I trimester) and breastfeeding.
Category actions result in FDA - B. (The study of reproduction in animals revealed no risk of adverse effects on the fetus, and adequate and well-controlled studies in pregnant women have not done.)
Side effects.
From the respiratory system: cough, tightness in the chest, difficulty breathing, bronchospasm.
From the nervous system: dizziness, headache.
From the digestive tract: abdominal pain (5%), unpleasant taste after inhalation, nausea, vomiting, dyspepsia.
Other: arthritis, neutron- or leukopenia, manifested by fever, sore throat or the whole body, fever, etc.. signs of infection.
Cooperation.
Strengthens (mutually) the effect of beta-adrenergic stimulants, corticosteroids, methylxanthine derivatives, ipratropiya bromide.
Dosing and Administration.
Inhalation. Adults and children over 12 years of the initial dose is 2 inhalation (4 mg) 4 once a day, optionally up to 6-8 times per day, for maintenance therapy - by 2 inhalation 2 once a day; supplementation is possible immediately before exercise to prevent asthma physical effort.
Precautions.
Aerosol is not intended for the relief of acute bronchospasm.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More